Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Change in Receivables (2019 - 2025)

Historic Change in Receivables for InfuSystem Holdings (INFU) over the last 10 years, with Q3 2025 value amounting to $78000.0.

  • InfuSystem Holdings' Change in Receivables fell 4620.69% to $78000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 4319.88%. This contributed to the annual value of $701000.0 for FY2024, which is 7033.43% down from last year.
  • As of Q3 2025, InfuSystem Holdings' Change in Receivables stood at $78000.0, which was down 4620.69% from -$6000.0 recorded in Q2 2025.
  • InfuSystem Holdings' 5-year Change in Receivables high stood at $2.1 million for Q1 2025, and its period low was -$647000.0 during Q4 2024.
  • Moreover, its 5-year median value for Change in Receivables was $145000.0 (2024), whereas its average is $292368.4.
  • As far as peak fluctuations go, InfuSystem Holdings' Change in Receivables tumbled by 28901.1% in 2022, and later skyrocketed by 78396.62% in 2025.
  • Over the past 5 years, InfuSystem Holdings' Change in Receivables (Quarter) stood at -$612000.0 in 2021, then skyrocketed by 189.22% to $546000.0 in 2022, then soared by 143.22% to $1.3 million in 2023, then plummeted by 148.72% to -$647000.0 in 2024, then soared by 112.06% to $78000.0 in 2025.
  • Its Change in Receivables was $78000.0 in Q3 2025, compared to -$6000.0 in Q2 2025 and $2.1 million in Q1 2025.